Peanut (Arachis hypogaea) allergy represents one of the most severe and persistent food hypersensitivities globally, affecting a significant percentage of the pediatric and adult population. Unlike many childhood food allergies (such as milk or egg) that are often outgrown, peanut allergy tends to be lifelong and carries a high risk of life-threatening anaphylaxis. The molecular basis of this allergenicity lies in specific seed storage proteins and defense proteins, designated as the "Ara h" series. This review examines the classification of these allergens, their distinct immunological mechanisms, the role of thermal processing in allergenicity, and the clinical relevance of component-resolved diagnostics in managing peanut-associated diseases.
Introduction to the Ara h Series
The peanut, technically a legume rather than a true nut, possesses a complex protein profile. To date, the World Health Organization and International Union of Immunological Societies (WHO/IUIS) have recognized over 17 distinct peanut allergens, named Ara h 1 through Ara h 17. These proteins are not created equal; they differ vastly in their abundance within the kernel, their structural stability, and their ability to trigger immune responses.
The majority of the allergenic burden is attributed to the seed storage proteins. These proteins serve as the nutrient reserve for the plant embryo but act as potent antigens in susceptible humans. They are broadly categorized into three families: the cupins (vicilins and glycinins), the prolamins (2S albumins), and the profilins/Bet v 1-homologues. Understanding the specific nature of these proteins is crucial because the clinical outcome—ranging from mild oral itching to fatal systemic shock—often depends on which specific "Ara h" protein the patient’s IgE antibodies recognize.
Figure 1. Ribbon representations of the known structures of peanut allergens. (Source: Palladino C, et al. 2018)
The Major Allergens: Ara h 1, 2, 3, and 6
The "major" allergens are defined as those recognized by more than 50% of peanut-allergic patients. Historically, Ara h 1 was the first to be characterized. It is a vicilin (7S globulin), a large trimeric protein that comprises a significant portion of the peanut's total protein mass. Ara h 1 forms stable homotrimers that are highly resistant to heat and digestion. This structural stability allows the protein to pass through the stomach largely intact, presenting large epitopes to the immune system in the gut, which facilitates sensitization.
However, despite the abundance of Ara h 1, modern research has identified Ara h 2 (a 2S albumin) as the most clinically dangerous allergen. Although it makes up a smaller fraction of the peanut protein content than Ara h 1, Ara h 2 is significantly more potent in releasing histamine from mast cells. It is a small, compact protein held together by disulfide bridges, rendering it exceptionally resistant to tryptic digestion and extreme pH changes. Ara h 6, another 2S albumin, shares significant structural homology with Ara h 2. Studies suggest that Ara h 2 and Ara h 6 often act synergistically; eliminating these two proteins alone can drastically reduce the effector activity of crude peanut extract.
Ara h 3 (a glycinin or 11S globulin) completes the triad of major seed storage proteins. While similar to Ara h 1 in its function as a storage protein, it generally possesses a lower IgE binding affinity compared to Ara h 2. Nevertheless, sensitization to Ara h 1, 2, and 3 simultaneously is a strong marker for true clinical allergy, as opposed to mere sensitization without symptoms.
Minor Allergens and Cross-Reactivity (Ara h 8 and 9)
Not all peanut "allergies" carry the same risk. This discrepancy is largely explained by the minor allergens, specifically Ara h 8 and Ara h 9. Ara h 8 is a pathogenesis-related protein (PR-10) that is structurally homologous to Bet v 1, the major birch pollen allergen. Patients with birch pollen allergies often experience "Oral Allergy Syndrome" (OAS) when eating raw peanuts. This is because their IgE antibodies, originally created to fight pollen, cross-react with Ara h 8. Crucially, Ara h 8 is heat-labile; it is destroyed by cooking and digestion. Therefore, patients sensitized only to Ara h 8 usually experience mild itching in the mouth and throat but rarely systemic anaphylaxis.
Conversely, Ara h 9 is a Lipid Transfer Protein (LTP). LTPs are pan-allergens found in many fruits (like peaches) and are highly stable. Sensitization to Ara h 9 is more common in Mediterranean regions and can lead to severe reactions, distinguishing it from the mild nature of the PR-10 family.
Mechanisms of Action and the "Roasting" Effect
The mechanism of peanut allergy follows the classic Type I hypersensitivity pathway. Upon initial exposure (via skin, gut, or respiratory tract), dendritic cells present peanut peptide fragments to T-helper cells (Th2), driving B-cells to produce specific Immunoglobulin E (IgE). These IgE antibodies coat the surface of mast cells and basophils. Upon subsequent exposure, the Ara h proteins bridge two adjacent IgE molecules on the cell surface, triggering the explosive release of inflammatory mediators like histamine, leukotrienes, and cytokines.
A unique feature of peanut allergens—particularly Ara h 1 and Ara h 2—is how they interact with thermal processing. While cooking usually degrades proteins and lowers allergenicity for many foods (like apples or eggs), roasting peanuts actually increases their allergenicity. Research has shown that the Maillard reaction (browning) modifies the protein structure, creating advanced glycation end-products. These modifications stabilize the protein structure further and can create new IgE binding sites (epitopes) or make existing ones more accessible. This phenomenon helps explain why peanut allergy is more prevalent in Western countries where dry-roasted peanuts are consumed, compared to Asian countries where peanuts are often boiled or fried, processes that may result in lower IgE binding capacity.
Clinical Manifestations and Related Diseases
The spectrum of disease caused by Ara h proteins is broad. The most acute presentation is anaphylaxis, characterized by urticaria (hives), angioedema (swelling), respiratory distress, and hypotension. Because Ara h 2 and Ara h 6 are so resistant to digestion, they are rapidly absorbed into the bloodstream, leading to systemic reactions minutes after ingestion.
Beyond acute anaphylaxis, peanuts are a common trigger for Atopic Dermatitis (Eczema). There is strong evidence supporting the "dual-allergen exposure hypothesis," which suggests that exposure to peanut protein through a disrupted skin barrier (eczema) leads to sensitization, while early oral exposure induces tolerance.
Furthermore, Component-Resolved Diagnostics (CRD) has revolutionized the management of these diseases. In the past, a patient might test positive for "whole peanut extract" due to a harmless cross-reaction with grass or birch pollen (Ara h 8). This led to unnecessary dietary restrictions. Today, clinicians look for specific IgE to Ara h 2. High levels of sIgE to Ara h 2 are the gold standard for predicting a risk of systemic reaction, often removing the need for risky oral food challenges.
Figure 2. Diagnostic flowchart for adults with suspected peanut allergy. (Source: Kansen HM, et al. 2021)
Frequently Asked Questions (FAQ)
Ara h 2 is widely considered the most clinically significant and "dangerous" allergen. It is highly resistant to digestion and heat, and sensitization to Ara h 2 is the strongest predictor of clinical anaphylaxis. While Ara h 1 is more abundant by mass, Ara h 2 has a higher potency for triggering histamine release from mast cells.
Generally, patients sensitized only to Ara h 8 (and not Ara h 1, 2, or 3) tolerate peanuts well, especially if they are cooked. Ara h 8 is a pollen-related protein (cross-reactive with birch pollen) that is easily destroyed by gastric acid and heat. Symptoms are typically limited to the mouth and throat (Oral Allergy Syndrome). However, clinical advice from an allergist is essential before introducing peanuts into the diet.
Allergic reactions are triggered by proteins (the Ara h series). Highly refined peanut oils undergo processing (high heat, solvent extraction, bleaching) that removes virtually all protein content. Therefore, the "Ara h" allergens are absent. However, cold-pressed, gourmet, or unrefined peanut oils may still contain intact proteins and pose a significant risk.
No, it often has the opposite effect. Unlike many other foods where cooking breaks down allergens, roasting peanuts at high temperatures (dry roasting) can enhance the allergenic properties of Ara h 1 and Ara h 2 via the Maillard reaction. Boiled peanuts, conversely, have shown reduced IgE binding capacity in some studies, but they still remain allergenic to sensitive individuals.
Sensitization means a person has detectable specific IgE antibodies (sIgE) to peanut proteins (e.g., a positive blood test or skin prick test). Allergy is when that sensitization leads to actual clinical symptoms (hives, vomiting, wheezing) upon ingestion. Many people can be sensitized (have IgE) without having clinical reactions. Component-Resolved Diagnostics (CRD) helps distinguish between the two by identifying which specific proteins (Ara h 2 vs. Ara h 8) are driving the immune response.
References
- Maleki SJ, et al. Structure of the major peanut allergen Ara h 1 may protect IgE-binding epitopes from degradation. J Immunol. 2000 Jun 1;164(11):5844-9.
- Beyer K, et al. Effects of cooking methods on peanut allergenicity. J Allergy Clin Immunol. 2001 Jun;107(6):1077-81.
- Bublin M, et al. Cross-reactivity of peanut allergens. Curr Allergy Asthma Rep. 2014 Apr;14(4):426.
- Palladino C, et al. Peanut allergens. Mol Immunol. 2018 Aug;100:58-70.
- Kansen HM, et al. Accurate Prediction of Peanut Allergy in One-Third of Adults Using a Validated Ara h 2 Cutoff. J Allergy Clin Immunol Pract. 2021 Apr;9(4):1667-1674.e3.